Clinical Trials at Houston Methodist Sugar Land Hospital
As of August 2026, 16 paid clinical trials are recruiting at Houston Methodist Sugar Land Hospital, located at 16655 SOUTHWEST FWY, SUGAR LAND, TX 77479-2329, phone (281) 274-7000 in Sugar Land, Texas. Active studies at this site cover conditions such as Obesity, Overweight and Atopic Dermatitis. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
16 clinical trials at Houston Methodist Sugar Land Hospital
·Clear filters·Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Common conditions studied in Sugar Land
- Obesity (9 active studies)
- Overweight (7 active studies)
- Atopic Dermatitis (6 active studies)
- Breast Cancer (4 active studies)
- Narcolepsy Type 1 (4 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (3 active studies)
Leading research sponsors in Sugar Land
- Pfizer
- NRG Oncology
- National Cancer Institute (NCI)
- AstraZeneca
- Alkermes, Inc.
Frequently asked questions
How many paid clinical trials are currently recruiting in Sugar Land?
There are approximately 132 recruiting clinical trials in Sugar Land, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Sugar Land pay participants?
Most recruiting trials in Sugar Land compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Sugar Land?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Sugar Land?
The most common conditions under active study in Sugar Land include Obesity (9), Overweight (7), Atopic Dermatitis (6), Breast Cancer (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Sugar Land?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Sugar Land on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Sugar Land?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Sugar Land?
Recruiting research sites in Sugar Land include Houston Methodist Sugar Land Hospital, MD Anderson in Sugar Land, UT MD Anderson - Sugar Land, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Sugar Land right now?
The largest active categories in Sugar Land are Cancer & tumors (48), Diabetes & metabolic (16), Eye & vision (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Houston Methodist Sugar Land Hospital?
Houston Methodist Sugar Land Hospital is located at 16655 SOUTHWEST FWY, SUGAR LAND, TX 77479-2329. Use the Google Maps link in the intro above to get directions.
How do I contact Houston Methodist Sugar Land Hospital?
You can reach Houston Methodist Sugar Land Hospital by phone at (281) 274-7000. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.